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Epidemiological models contain a set of parameters that must be adjusted based on available
observations. Once a model has been calibrated, it can be used as a forecasting tool to make
predictions and to evaluate contingency plans. It is customary to employ only point estimators for
such predictions. However, some models may fit the same data reasonably well for a broad range of
parameter values, and this flexibility means that predictions stemming from such models will vary
widely, depending on the particular parameter values employed within the range that give a good
fit. When data are poor or incomplete, model uncertainty widens further. A way to circumvent this
problem is to use Bayesian statistics to incorporate observations and use the full range of parameter
estimates contained in the posterior distribution to adjust for uncertainties in model predictions.
Specifically, given the epidemiological model and a probability distribution for observations, we use
the posterior distribution of model parameters to generate all possible epidemiological curves via
the posterior predictive distribution. From the envelope of all curves one can extract the worst-case
scenario and study the impact of implementing contingency plans according to this assessment. We
apply this approach to the potential evolution of COVID-19 in Mexico City and assess whether
contingency plans are being successful and whether the epidemiological curve has flattened.
EXECUTIVE SUMMARY
In this working document we present results on the evolution of the epidemic of COVID-19 in Mexico City. We use
a Kermack-McKendrick type of model with the following compartments: susceptible, exposed, infected, hospitalised,
critical, recovered, and diseased. The model is calibrated with data that have been made publicly available by
Secretar´ıa de Salud. Our conclusions are the following:
1. Calibration of this type of models is fairly complicated, particularly when using data from the beginning of the
epidemic. Moreover, this problem worsens due to uncertainties in the available data (e.g. subnotification).
2. Without correcting for the sentinel system or mitigating factors, it seems that Mexico City has managed to
flatten the curve, albeit mildly, and the peak of the epidemic for new daily infected cases has moved from mid
May to mid June.
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23. The analysis of this model using synthetic data suggests that model calibration will improve considerably once
we pass the peak of the epidemic.
Based on this analysis our observations and recommendations are the following:
1. Due to problems inherently associated to this type of models, which are compounded with the inadequacy of
the data, whichever decisions are made based on the initial stages of the epidemic curve alone (e.g. activation
of transmission-mitigating protocols) must be made considering the worst case scenario. When dealing with
emerging diseases, public health decisions should be data-driven, taking into consideration the experience of
other countries. Models, at this stage, should be used as a rough guideline.
2. Once the peak of the epidemic curve has passed, epidemiological models become more reliable, providing more
precise predictions, which can be used to decide when and how containment measures may be lifted (e.g. gradual
return to economic activities, reopening of schools and universities, etc.).
I. INTRODUCTION
The last month of 2019 saw the start of an outbreak in Wuhan, China, that was to be recognised as a new
coronavirus able to infect humans and transmit within human populations. Fast isolation on the 7th of January led to
publication of its genetic sequence on January 12th and its identification as a novel coronavirus (2019-nCoV) [1]. One
day later, the first case outside China would be reported in Thailand. By January 23, Chinese authorities had taken
severe measures to contain its spread, imposing travel bans, restricting mobility within Wuhan, isolating suspect and
confirmed cases, banning gatherings and shutting schools and entertainment venues. This did not prevent the virus
from reaching several other countries and all regions of China quickly. On January 30, with 7,736 confirmed cases
in China and 82 in other countries, the World Health Organisation declared SARS-CoV-2 a Global Public Health
Emergency. By February 8, with 813 deaths, SARS-CoV-2 had surpassed the death toll of SARS (final toll, 774), and
only a day later, that of MERS [2].
Mexico confirmed its first two cases of Covid-19 on February 28th in travellers returning from Italy to Sinaloa and
the State of Mexico respectively. Phase 2 of the epidemic would be declared on March 23, and phase 3 nearly a month
later, on April 20th.
On March 15th, the Mexican National Committee for Safety in Health (Comite´ Nacional para la Seguridad en
Salud) announced the start, on March 23rd, of distancing measures to mitigate the transmission of the virus causing
the COVID-19 disease in Mexico. These included suspending all non essential activities of public, private and social
sectors. This suspension would first last until April 30th, but was further extended until May 30th, and was designed
to lower disease incidence rates of COVID-19 and keep the number of critical cases manageable. On March 18th,
the Ministry of Health (Secretar´ıa de Salud) [3] announced that a total of 250 656 COVID-19 cases were expected
in the country over the course of the epidemic, which amounts roughly to 0.0019 of the total population of Mexico
estimated around 128.7 million in 2020 [4]. On the same date it was informed [3] that the Federal Health Sector of the
country currently had 4291 beds and 2053 ventilators in Intensive Care Units (ICUs). The phase 3 of the epidemic
was declared on April 23rd, and by May 3rd, 23 471 confirmed cases had been reported in the country, with 2 154
deaths [5]. By the same date, in Mexico City the number of confirmed cases and the number of hospitalized COVID-19
patients are 6 417 and 3 099, respectively [6]. The challenge, then, is to ensure that this hospital capacity is not
surpassed by the demand at any time during the course of the epidemic in Mexico. The number of actual infected
cases, however, both in Mexico City and the country at large, is expected to be larger than the above numbers indicate
due to sub-reporting and to the existence of a large proportion of asymptomatic carriers of COVID-19 [7]. The strain
on the Health system is already important in Mexico City and other large population centers in the country.
Most countries have resorted to studies based on epidemic data from China in order to understand and manage
their outbreaks. A first step has been to try and estimate disease-specific parameters. Recent work [8] has reported
that the mean duration from onset of symptoms to death is 17.8 days (95% CI 16.9-19.2 days), and the mean duration
from symptom onset to hospital discharge is 22.6 days (95% CI 21.1-24.4 days). The same paper has estimated the
overall infection fatality rate for China to be 0.66% (0.39-1.33) with higher numbers for older ages. Also, they report
that the percentage of individuals likely to be hospitalized increases with age to a maximum of 18.4% (11.0-7.6).
Mizumoto et al. [9] report, from their study of the Diamond Princess cruise ship, a proportion of asymptomatic cases
of 17.9% (95% CI 15.5-20.2) with this estimate sensitive to the mean incubation period assumed. Nishiura et al. [10],
using data from Wuhan, China, estimate the asymptomatic ratio (percentage of carriers with no symptoms) to be
higher, at 30.8% (95% CI 7.7-53.8). Wang et al [11], reviewed in Nature news on March 20th 2020, report a varying
average daily attack rate per million people for Wuhan depending upon on the evolution of the epidemic: 2.2 (95%
CI 2.0-2.4) before January 11, 44.9 (43.6-46.2) between January 11 and January 22nd, 150.9 (148.3-153.5) between
3January 23rd and February 1st, and 54.1 (52.9-55.3) after February 2nd. However, differences in this rate were found
depending upon age and risk group (healthcare professionals). As for the severity of the disease, these authors report
49.9% mild, 27.4% moderate and 19.7% severe, although they point out that this last percentage decreased gradually
to reach 14.7% in the last phase of the epidemic.
Health authorities in Mexico are apparently estimating the overall attack rate to be well below the highest attack
rate reached in China (Jan 23rd-Feb 1st) of 150.9 per million people. However, the percentage of asymptomatic cases
is in accordance with Nishiura et al. [10] estimate. The percentage of people requiring hospitalization is lower (9.8%)
than the maximum of 18.4% reported (also for China) in [8].
Parameter Median 95% credible interval or Range Reference
Infection →onset of symptoms τl 5.1 d 4.5-5.8 d [12]
Onset of symptoms → Death 17.8 d 16.9-19.2 d [8]
Onset of symptoms → hospital discharge 24.7 d 22.9-28.1 d [8]
Serial interval (≈ τi) 6.5 d 5-8 (range) d [13]
Prob. severe symptoms → ICU 0.36 adults, 0.2 seniors - [14]
Hospitalized → R rate 0.072 adults, 0.022 seniors (1/d) - [14]
Hospitalized → D rate 0.0042 adults, 0.014 seniors (1/d) - [14]
ICU → R rate 0.05 adults, 0.036 seniors (1/d) - [14]
ICU → D rate 0.0074 adults, 0.029 seniors (1/d) - [14]
R0 2.4 2-4.5 [15]
TABLE I. In this table we show some examples of estimated parameters from studies carried out in different countries
It must be said, however, that the estimates vary wildly from country to country. Thus, comparing fitted parameters
between different countries to either disregard or confirm a particular model may be misleading. It would be rather
more sensible to run different models for a given population and compare the results for that particular setting.
Regarding the reasons as to why fitted parameters vary wildly from country to country —one may speculate— are
age distribution, risk factors, income inequality, free access to healthcare, social norms, to mention but a few.
In this scenario, mathematical models are a natural tool for identifying what needs to be done in order to meet
the pressing challenge. Models are commonly used to estimate, for example, the extent of the reduction in the
effective transmission rate needed to control an epidemic in a specific manner. However, most of these models fall in
a category commonly known as sloppy models [16]. These are models that depend on a large number of parameters
and for which, once fitted to data, a broad range of certain parameter values produce similarly acceptable fits. This
is clearly disconcerting, since using different parameter estimates one will surely obtain widely different predictions
from the same model, rendering its application to forecasting impractical, a problem which unfortunately is frequently
overlooked at times when theoretical expectations and scientific rigour are directly needed.
Here, we present a Kermack-McKendrick type of model [17] to evaluate the efficacy of the Sanitary Emergency
declaration in containing disease spread in Mexico City, taking into account parameter uncertainty and data scarcity.
One way to tackle these uncertainties is to use a Bayesian approach and analyse whether the mitigation measures
are being effective and what are the worst-case scenarios to be expected. Specifically, we introduce the predictive
posterior distribution for epidemiological models. This allows us to analyse a full spectrum of scenarios, thus enabling
us to determine whether the response is being appropriate in order to avoid the collapse of the health system. Instead
of accurately calibrating models with data, which is a difficult task to carry out with the short time series from the
early stage of an epidemic, we focus on the effects of parameter variability in the model’s predictions.
The remaining part of the paper is organized as follows: in Section II we discuss epidemiological models, and
introduce their predictive posterior distributions. In Section III, we use these results to analyse the current situation
in Mexico City. We conclude in Section IV, with a discussion and an outline for future work.
II. ON EPIDEMIOLOGICAL MODELS
The basic idea of epidemiological compartmental models is to split the host population (often assumed to be of
constant size N) into r compartments corresponding to states of the infection, so that Na(t) indicates the population
in state a = 1, . . . , r. We thus introduce vector N (t) = (N1(t), . . . ,Nr(t)) and assume the epidemic to follow a set of
4nonlinear ODEs
dN (t)
dt
= F [N (t),θ] , (1)
where θ = (θ1, . . . , θp) is a set of p parameters of the model. Let N (t,θ) denote the solution for the set of equa-
tions (1) given the parameters θ. Examples of simple epidemiological models are the Susceptible-Infected-Recovered
(SIR) or the Susceptible-Exposed-Infected-Recovered (SEIR) models, for which the states are N = (S, I,R) or
N = (S,E, I,R), respectively. More realistic models, as the one we will use here, with the aim to estimate disease
toll and burden, further introduce additional states to follow hospitalize and critically-ill patients.
Suppose now that we have an observational dataset D ≡ {N (obs)(t)}tmaxt=0 , possibly with an observational time-
and compartmental-correlation matrix. From here we can derive the likelihood P (D|θ) of observing this dataset
given a set of parameters. Using Bayes’ rule, the posterior distribution of the parameters given the dataset is simply
P (θ|D) ∝ P (D|θ)P0(θ) where P0(θ) is the prior distribution of the parameters. The standard way to calibrate the
model then corresponds to finding the set of parameters, denoted here as θ?, which maximizes the posterior distri-
bution P (θ|D), that is, θ? = arg maxθP (θ|D). These are sometimes referred to as maximum a posteriori (MAP)
estimators, and there are various efficient ways to obtain them without exploring the whole posterior distribution.
When the prior distribution is flat, and the posterior distribution exists, θ? coincides with the maximum likelihood
estimator. Once the model has been calibrated using this point estimator, the evolution of the epidemic is given by
N (t,θ?), which can then be used to make predictions.
Unfortunately, this method tends to fail for the so-called sloppy models [16], because the variances in parameter
calibration can be rather large in certain directions of the parameter space, particularly when one is only using a
dataset of the beginning of the epidemic curve. As a result, there is large uncertainty in the conditions leading
to the desired state, which renders this deterministic approach inadequate as a forecasting tool to e.g. implement
contingency plans. A full Bayesian approach considers the uncertainty captured by the whole posterior distribution
P (θ|D), and not only the deterministic point estimator θ?. Consequently, it is better to work with the posterior
predictive distribution given by:
P (n, t|D) =
∫
dθP (θ|D)P [N (t,θ) = n | θ] , (2)
where P [N (t,θ) = n | θ] = δ[n − N (t,θ)], since the evolution equations (1) modelling the epidemic are deter-
ministic. Here P (n, t|D) = Prob(N (t,θ) = n | D) corresponds to the probability of observing a given value of
the state n = (n1, . . . , nr) at time t given the data set D. Clearly, if P (θ|D) has a marked peak around θ?, be-
ing the extreme case P (θ|D) = δ(θ − θ?), then P (n, t|D) evolves deterministically according to N (t,θ?), that is
P (n, t|D) = δ [n−N (t,θ?)], recovering the previously mentioned standard approach. However, if the posterior dis-
tribution P (θ|D) is widely spread, so will be P (n, t|D). Thus, we need to consider the whole distribution P (n, t|D)
as a forecasting tool, and use it to analyse the implementation and impact of contingency plans.
Generally, we expect the posterior predictive distribution P (n, t|D) to have a compact support since the host pop-
ulation is constant. With this in mind, we will denote as Ω(low)(t) and Ω(up)(t) its lower and upper boundaries,
respectively, that is, P (n, t|D) is zero for n 6∈ [Ω(low)(t),Ω(up)(t)]. These two boundaries Ω(low)a (t) and Ω(up)a (t),
which correspond fairly intuitively to the lower and upper enveloping curves of all possible epidemiological curves
N (t,θ) with θ drawn from P (θ|D), can be understood in epidemiological terms to to the best- and worst-case sce-
narios of the epidemic for state a at time t, respectively. Thus, they are fairly useful to determine the impact on
a healthcare system. For instance, if we were to have a compartment C modelling critically-ill patients, the corre-
sponding upper boundary Ω
(up)
C (t) gives a bound for the worst-case scenario. Thus, if a particular healthcare system
has a given maximum capacity, denoted here as B (e.g. total Intensive Care Units available) to treat critically-ill
patients, then having Ω
(up)
C (t) > B at some point indicates that the healthcare system has demands exceeding its
capacity. A careful, and successful, contingency plan must consider the worst possible outcome of the epidemic, so
that implemented measures guarantee that Ω
(up)
C (t) < B.
Equally important is to derive when the peak of the epidemic curve will take place. A Bayesian approach feels again
naturally suited to analyze this. Let t
(a)
peak = argmaxtNa(t,θ) be the time at which the epidemic will reach its peak
for compartment a. The corresponding posterior predictive distribution of peak times is:
P
({
t
(1)
peak, . . . t
(r)
peak
} ∣∣∣D) = ∫ dθP (θ|D) r∏
a=1
δ
[
t
(a)
peak − argmaxtNa(t,θ)
]
. (3)
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A. Estimation of the parameters’ posterior distribution
To construct the parameter’s posterior distribution P (θ|D), we first need to discuss the choices of the model’s
likelihood P (D|θ) and the prior distribution P0(θ).
Taking into account a possibly rather large value N of the host population, and since it is not possible to have the
empirical correlation matrix for the observational data, we take the model’s likelihood to be:
P (D|θ) = 1√
(2pi)rtmax
exp
[
−1
2
tmax∑
t=0
r∑
a=1
(
Na(t,θ)−N (obs)a (t)
)2]
, (4)
where we have assumed that the observational data-set are independent and identically distributed Gaussian variables
with unit variance, and tmax is the time of the last recorded data. Granted, this is a gross over-simplification as, in
principle, these data are time and compartment correlated and one would need the corresponding empirical correlation
matrix, for which we have no information.
Regarding the choice of P0(θ), in principle it would seem appropriate to consider an empirical a priori distribution
by gathering the resulting values of parameters θ coming from studies from other countries. While this approach is
indeed tempting from a statistical point of view, it assumes that health conditions, comorbidities and other important
aspects are homogeneous among different countries, which is clearly untrue. Thus a cautious approach, and in order
to avoid any confirmation bias, is to use a flat prior within a range of parameters θa ∈ [θ(min)a , θ(max)a ], where the
boundaries of the parameters are reasonably wide enough to be compatible with the available data from other studies,
that is
P0(θ) =
1
Z0
r∏
a=1
I
{
θa ∈ [θ(min)a , θ(max)a ]
}
, (5)
where Z0 is a normalization constant of the prior distribution and I is an indicator function.
Given that the explicit solution to Eq. (1) is not always available, the resulting parameter’s posterior distribution
P (θ|D) is a rather complicated function of θ, so that the natural way to carry out the integrals appearing in Eqs.
(2) and (3) is by numerically estimating P (θ|D) by a Monte Carlo method. As one normally has observational data
at the beginning of the epidemic curve, and since we are dealing here with sloppy models, the parameter’s posterior
distribution is rather flat in most of the directions of the parameter space. This indicates that the most efficient
approach is first to solve the minimization problem
θ? = argmaxθ∈[θ(min),θ(max)]P (D|θ) , (6)
and then to explore uniformly the space of parameters around the point θ?, by randomly perturbing it with a random
variable , that is θ? → θ = θ? + η, with η controlling the spread of the exploration in the parameter space. In
this way one can easily generate a sequence of random numbers {θα}Nsampleα=1 , that will allow us to explore the most
probable region around the mode θ?, and from which we estimate both posterior predictive distributions given by
Eqs. (2) and (3), that is
P (n, t|D) ' 1Nsample
Nsample∑
α=1
δ [n−N (t,θα)] , (7)
P
({
t
(1)
peak, . . . t
(r)
peak
} ∣∣∣D) ' 1Nsample
Nsample∑
α=1
δ
[
t
(a)
peak − argmaxtNa(t,θα)
]
, (8)
respectively.
B. Model selection
As for the model, there are many variants already reported in the literature that include the compartments consid-
ered here. We have chosen to follow the one used in [18, 19] (and references therein). Here, susceptible individuals S
6become exposed (E) to the virus through contact with infected individuals I. Exposed individuals progress towards
the symptomatic state I within an average time τ`. As usual, mixing is assumed to be homogeneous. Infected indi-
viduals I cause an average of R0 secondary infections over their infectious period. After an average time τi (days),
infected individuals either recover or progress towards hospitalization. In turn, hospitalized individuals H either
recover or worsen towards a critical state after a time τh. Critical individuals C allow us to model ICU demand. They
either return to the hospital stage or die, moving to D, after a time scale τc. Recovered individuals R are assumed to
be immune. The dynamics of this model is given by the following set of differential equations:
dS(t)
dt
= −β(t)S(t)I(t)
N
(9)
dE(t)
dt
= β(t)
S(t)I(t)
N
− E(t)
τ`
(10)
dI(t)
dt
=
E(t)
τ`
− I(t)
τi
(11)
dH(t)
dt
= (1−m)I(t)
τi
+ (1− f)C(t)
τc
− H(t)
τh
(12)
dC(t)
dt
= c
H(t)
τh
− C(t)
τc
(13)
dR(t)
dt
= m
I(t)
τi
+ (1− c)H(t)
τh
(14)
dD(t)
dt
= f
C(t)
τc
. (15)
The fraction of infections that are mild is m, the fraction of cases that turn critical is c, and the fraction of critical
cases with fatal outcome is f . Other variants of the model consider, for instance, a recovery time for mild infections
which is different from τi, or a fraction of those infected that are asymptomatic. Equations (9)-(15) provide a relatively
simple description of epidemic dynamics, including entry to and exit from the hospital, that allows us to focus in the
number of hospitalized and critical cases, and foresee whether health services will be saturated. The transmission
parameter in the model is taken to be
β(t) =
R0M(t)
τi
(16)
where R0 is the basic reproduction number, and M(t) captures the mitigation measures. While generally speaking
pathogens affect populations in an uneven way, due to heterogeneity in the risk experienced by age, comorbidities or
other factors (e.g. behaviour, nutrition and so on), for simplicity we assume a population homogeneous in all respects.
A generalization to include how a particular age distribution affects model evolution is straightforward [18], and is
ongoing work.
Before embarking into the difficult task of calibrating the model using the open data of SARS-CoV-2 cases in Mexico
City, we sought to develop some intuition of the model’s behaviour. Consequently, we addressed how the calibration
behaves depending on the time window considered for the observational data. For an arbitrary, yet realistic, choice
of the parameters, we generated a synthetic data set {N (syn)(t)}tmaxt=0 and explore the MAP problem in terms of tmax.
We observed that for tmax < tpeak the posterior distribution is indeed rather flat while for tmax > tpeak, a more
defined maximum appears and the model can be more easily calibrated. We must emphasize that these observations
are neither new nor remarkable properties for this type of models. However, whichever analysis is performed on these
models, particularly as a forecasting tool that considers only the beginning of the epidemic curve, must be carried
out reckoning these properties.
C. Analysis and results for COVID-19 in Mexico City
We have applied this approach to study the evolution of the spread of SARS-CoV-2 in Mexico City, by using the
public data-base provided by Secretar´ıa de Salud corresponding to April 29th [20, 21]. From here, we have considered
the data starting from February 27th (which we denote as t = 0) until April 19th. The database allows to extract
the time series for the incidence (new cases) of infected individuals, of hospitalised and of critically-ill (complicated
hospitalisations including the use of respirators), as well as the total number of deceased patients, both positively
confirmed of being infected of SARS-CoV-2 and the suspected cases, waiting for the results of RT-PCR tests. Note
that the new cases do not correspond to the number of cases in each compartment, information which is unavailable
7from the data. When calibrating the model we have considered a cautious approach to add to the confirmed cases half
of the suspected ones for each of the mentioned compartments. Clearly, not all suspected cases will be confirmed as
SARS-CoV-2, since this epidemic is concurrently happening with other seasonal diseases; yet, we believe it important
to include those as they aggregate to the use of the healthcare system. We also know that the contingency plan was
firstly activated March 23rd, so we take the mitigating function M(t) to be one prior that date and a constant equal
to γ after that day.
All in all, given the data, we need to determine the model’s parameters θ = (τi, τ`, τh, τc,m, c, f, R0, γ), with initial
conditions (S(0), E(0), I(0) = 4, H(0) = 2, C(0) = 1, R(0) = 0, D(0) = 0). Notice that since we are unaware of the
initial conditions for S(0) and E(0) we will also consider them as parameters to be fitted. The value of N is such that
N = S(0) + E(0) + I(0) +H(0) + C(0) +R(0) +D(0) and each parameter is allowed to take values in the following
range: τi ∈ [4, 9], τ` ∈ [4, 6], τh, τc ∈ [3, 15], m, f ∈ [0.2, 0.8], c ∈ [0.2, 0.7], S(0) ∈ [0, 0.9Npop], R0 ∈ [0.8, 5], and
γ ∈ [0, 1], where Npop is the population of the Mexico City of around 9 million. Table II shows the resulting optimal
parameters θ?, with with optimal initial susceptible and exposed population being S(0) = 182798 and E(0) = 16,
respectively.
Model’s parameters Interval range Optimal parameters
τi [4,9] 9.0 days
τ` [4,6] 4.0 days
τh [3,15] 9.9 days
τc [3,15] 3.0 days
m [0.2,0.8] 0.49
c [0.2,0.7] 0.7
f [0.2,0.8] 0.8
R0 [0.8,5] 2.94
γ [0,1] 0.83
TABLE II. Values of optimal parameters found by maximizing the parameter’s posterior distribution.
The first observation is that before the contingency plan the R0 = 2.94 and after its activation this number is
reduced to R0× γ = 2.44, indicating that we have managed to mildly flatten the curve. From our parameters, we can
also estimate the rate (in days−1) of passing from one compartment to another. This is shown in table III.
Estimates Quantity Rates (in days)−1
Onset of symptoms → Recovery m/τi 0.05
Onset of symptoms → Hospitalization (1−m)/τi 0.06
Hospitalization → Critical state c/τh 0.07
Critical state→ Hospitalization (1− f)/τc 0.07
Critical state→ Death f/τc 0.3
Hospitalization → Recovery (1− c)/τh 0.03
TABLE III. Estimates of rates to pass between different compartments.
We can now use the expressions (7) and (8) to estimate the predictive posteriors. In both cases we have used a
value of η = 0.1. Figure 1 shows the resulting predictive posterior for daily new cases of infected, of hospitalized and
of critically-ill patients, as well as the total number of deaths. More precisely, in all cases, the solid red line correspond
to the calibrated model with θ?, the white markers correspond to the observational data, the density plots are the
values of the predictive posterior distribution and finally, the lower and upper dashed black lines are the best and
worst scenarios for each incidences.
These set of plots are fairly informative and it is worth to discuss them in detail. We first notice that by only
perturbing the deterministic solution (indicated by a solid red lines for each frame) by a small value of η, the solutions
spread fairly widely, with all the the possible epidemic curves encapsulated by the dashed black lines. Thus the
deterministic solution is very sensitive to parameter perturbations and thus unsuitable to be used as a forecasting tool
all by itself. Secondly, the density plots show that certain epidemic curves tend to accumulate. Interesting enough
there is an increment in the density of curves symmetrically distributed above and below of the deterministic curve
8FIG. 1. Results for daily new infected, hospitalized, and critical cases, as well as total number of deaths. In the first plot
we have indicated the meaning of each curve: solid red line corresponds to the deterministic prediction with the mitigation
plan, solid green line is the corresponding deterministic prediction without mitigation. The dashed solid lines comprised the
enveloping region for the predictive posterior, while the density plots is the actual value of the predictive posterior for the
corresponding compartment in each plot. Finally, the white markers correspond to the data for Mexico city.
at the beginning of the epidemic. It turns out that the increased density above the red solid line corresponds to a
resulting epidemic if no contingency plan would have been activated. This is indicated by a solid dark green line only
on the first plot. We thus conclude the the contingency plan was successful, albeit mildly, and did manage to flatten
the curve and move it to the right. Similarly the increased density of curves below the deterministic one indicate the
possibility of what would happen if the mitigating plan would have been more successful. We finally observe that the
deterministic curve for daily new critically-ill cases obtained is above the data, suggesting that we are overestimating
the total toll for the number of deceased.
We can similarly explore the posterior predictive distribution for peak times. These are shown in Fig. 2 for daily
new cases of infected, hospitalized and critically-ill patients, which were obtained according to Eq. (8) and using
a value of η = 0.1. These distributions are again very informative: they are bimodal distributions where the first
peak corresponds to that epidemic curve with no contingency plan, while the second peak is the one corresponding
to a fairly successfully executed one. These peaks and their spread correspond to the the increased density around
the deterministic curve discussed before. Thus, we conclude, that the current mitigating measures are somewhere in
between the two peaks and they have managed to postpone the day at which the peak of the epidemic will happen.
Interestingly enough, and admittedly that this holds for a fixed value of η, the support of the distribution of peak
times is compact. This means that we can provide a rather hard and robust interval within which the peak actually
happens. For instance, according to the left panel in Fig. 2, the peak for daily new infected cases will happen between
May 17th and July 16th, with the mean time for the peak of the epidemic being in June 1st and a standard deviation
of 15 days. A similar analysis follows for the other two posterior distributions for daily new hospitalized and critical
cases. Table IV summarises the most important information from these distributions.
9FIG. 2. Posterior predictive distribution of times at which the epidemic curves will peak for daily new infected (left panel),
hospitalized (middle panel), and critical (right panel) cases.
Daily new cases Mean date for peak to occur Standard deviation Date for peak without mitigation
Infected June 1st 15 days May 19th
Hospitalized June 9th 15 days May 27th
Critical June 18th 15 days June 5th
TABLE IV. Summary of properties from the posterior predictive distribution of times when the epidemic peaks.
IV. CONCLUSIONS AND FUTURE WORK
Contingency plans based on epidemiological models must be analysed and carried out very carefully. Even with fairly
accurate observational data, the importance of stochasticity inherent to the start of an epidemic means that parameter
estimates based on data from the beginning of an outbreak will be quite uncertain. In turn, models parametrised with
such data will carry great uncertainty in longer term forecasts. On the other hand, this uncertainty can be quantified
using techniques from Bayesian statistics, which may then be used to consider worst-case scenarios. Although the
model analysed here is simple, the main conclusion of this work is that extrapolating results without accounting for
sensitivity to changes in parameters can result in predictions way off the mark. We believe that the same conclusion
would hold for more detailed models, e.g., which include more specific details of the population, since most of them
are also sloppy.
With regards to Mexico City, our results show that we have so far managed to mildly flatten the curve and the
peak for daily new infected cases has been moved to likely occur in June 1st. However, this, and other compartmental
models applied to Mexico, are rather sensitive to parameter calibration. Having access to richer data containing more
epidemiological and clinical information, may help to control better the predictions of the present model.
The control of the epidemic curve of SARS-CoV-2 in Mexico City requires the evaluation of the mitigation strategies
that have, to date, being implemented in the country. Mathematical models are central to this effort but there are
conditions to be considered and measured for their efficient application. Mexico has the lowest testing rate among
the OCDE countries [22]. A high testing rate is recommended to adequately plan the lifting of mitigation restrictions
already in place. Moreover, testing is necessary to estimate the size of the epidemic. In Mexico, several hundred
Health Units constitute the country’s sentinel surveillance system where cases are detected and followed to identify
possible contacts of that case and other relevant information [23]. A case detected by symptomatic surveillance has
to be confirmed by testing but, to obtain a concrete, workable estimation of the epidemic, tests have to be widely
applied to the general population, not only to suspect cases already detected by the surveillance system. The positivity
test rate for SARS-CoV-2 in Mexico was around 15%-20% on April, 2020 [24], similar to that of the US [25]. This
high positivity rate and the limited number of tests currently applied may prevent an accurate estimate of the true
growth rate of the epidemic; in particular, the identification of the time of maximum incidence may be confounded.
Since tests are insufficient and, for the particular situation of the Mexican economy, increasing the testing rate is
unfeasible, mathematical modeling projections can help to evaluate the different scenarios that are consistent with
the observed trend of the epidemic curve. Our model provides projections based on confirmed cases that put the more
likely dates of maximum incidence towards the end of May or early June, 2020. Earlier dates are possible too but
with lower probability. These findings are important because the lifting of the Sanitary Emergency Measures, firstly
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implemented in late March in Mexico City, are programmed to end on May 30, 2020. If our scenarios are correct,
the risk of a new outbreak is high since lifting would coincide with the days of maximum incidence. Even if the
maximum incidence occurs on early May 2020, although the trend in incidence will be decreasing the following days,
the number of susceptible individuals will still be large since SARS-CoV-2 is a new virus. There is yet no significant
herd immunity in the population. Our model more likely projection, namely, that the incidence peak will occur in late
May, early June 2020, together with the crucial lack of sufficient testing to provide a more accurate estimate of the
number of people infected, provides support for the recommendation of a reevaluation and careful and slow release of
the mitigation and social-distancing measures to prevent a significant rebound of the epidemic.
As for future work, there are a number of avenues we are currently exploring, both theoretically from the modelling
side and as a predictive tool. For instance, we will shortly explore the impact that would have for Mexico City to lift
the medical emergency too soon. Clearly, we plan to extend this analysis to other regions of Mexico.
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